| Serial Number | 88922034 |
| Word Mark | KANTARO |
| Filing Date | Monday, May 18, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 8, 2022 |
| Registration Number | 6667509 |
| Registration Date | Tuesday, March 8, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 18, 2021 |
| Goods and Services | Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens and tissue; Assays, reagents, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agents, preparations, substances and diagnostic test kits primarily comprised of medical diagnostic reagents and assays, and also consisting of vessels, containers and implements being medical specimen collection and processing devices in the nature of tubes, swabs, bags, vials, laboratory bottles, cups, and laboratory pipettes for the collection and processing of blood, bodily fluids, biological and cellular samples and specimens and body tissue for performing serological and molecular tests, used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood, bodily fluids, biological and cellular samples and specimens and tissue for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Antibody diagnostic test for use in disease detection; Medical diagnostic test kits comprised of medical diagnostic assays, reagents, media, solutions in the nature of reagent solutions, substrate solutions, stop solutions, staining solutions, standard solutions and buffer solutions, buffers and diagnostic preparations for coronavirus, SARS-CoV-2 and COVID-19 diagnosis and monitoring |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 3, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, August 14, 2020 |
| First Use In Commerce Date | Friday, August 28, 2020 |
| Party Name | Kantaro Biosciences LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New York, NY 10036 |
| Party Name | Kantaro Biosciences LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New York, NY 10036 |
| Party Name | Kantaro Biosciences LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New York, NY 10036 |
| Event Date | Event Description |
| Tuesday, March 8, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 1, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, January 31, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, January 28, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, January 13, 2022 | USE AMENDMENT FILED |
| Friday, January 28, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, January 13, 2022 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, July 13, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 18, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 18, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 28, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 13, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 13, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, April 13, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 13, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 13, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, April 1, 2021 | ASSIGNED TO EXAMINER |
| Monday, March 1, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 26, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 26, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, November 8, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, November 8, 2020 | NON-FINAL ACTION E-MAILED |
| Sunday, November 8, 2020 | NON-FINAL ACTION WRITTEN |
| Saturday, November 7, 2020 | ASSIGNED TO EXAMINER |
| Wednesday, June 3, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, May 21, 2020 | NEW APPLICATION ENTERED IN TRAM |